Lotensin HCT - benazepril hydrochloride and hydrochlorothiazide
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0454 |
| Proprietary Name: | Lotensin HCT |
| Suffix: | |
| Non-Proprietary Name: | benazepril hydrochloride and hydrochlorothiazide |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 30-05-1992 |
| End of Marketing: | 30-11-2014 |
| Category Name: | NDA |
| Application Number: | NDA020033 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 20; 25 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |